Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination.


Dogan I., Paksoy N., Ak N., Vatansever S., Saip P., Aydiner A.

JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.16, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 40 Issue: 16
  • Publication Date: 2022
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Istanbul University Affiliated: Yes